806 related articles for article (PubMed ID: 21378570)
41. Rituximab for rheumatoid arthritis.
Palylyk-Colwell E; McGahan L
Issues Emerg Health Technol; 2006 Sep; (89):1-4. PubMed ID: 17014062
[TBL] [Abstract][Full Text] [Related]
42. Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or leflunomide, or cyclosporin-A monotherapy: a 48-week, comparative, prospective study.
Karanikolas G; Charalambopoulos D; Vaiopoulos G; Andrianakos A; Rapti A; Karras D; Kaskani E; Sfikakis PP
Rheumatology (Oxford); 2008 Sep; 47(9):1384-8. PubMed ID: 18603660
[TBL] [Abstract][Full Text] [Related]
43. [Biologics: current therapeutic strategies for rheumatoid arthritis].
Tanaka Y
Nihon Rinsho; 2007 Jul; 65(7):1179-84. PubMed ID: 17642229
[TBL] [Abstract][Full Text] [Related]
44. Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Symmons DP; Watson KD; Silman AJ;
Arthritis Rheum; 2006 Jun; 54(6):1786-94. PubMed ID: 16736520
[TBL] [Abstract][Full Text] [Related]
45. The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis.
Hansen KE; Cush J; Singhal A; Cooley DA; Cohen S; Patel SR; Genovese M; Sundaramurthy S; Schiff M
Arthritis Rheum; 2004 Apr; 51(2):228-32. PubMed ID: 15077264
[TBL] [Abstract][Full Text] [Related]
46. Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials.
Thompson AE; Rieder SW; Pope JE
Arthritis Rheum; 2011 Jun; 63(6):1479-85. PubMed ID: 21360522
[TBL] [Abstract][Full Text] [Related]
47. An update on methotrexate.
Braun J; Rau R
Curr Opin Rheumatol; 2009 May; 21(3):216-23. PubMed ID: 19373092
[TBL] [Abstract][Full Text] [Related]
48. [Infliximab in the treatment of rheumatoid arthritis].
Akahoshi T; Watabe H
Nihon Rinsho; 2002 Dec; 60(12):2378-83. PubMed ID: 12510365
[TBL] [Abstract][Full Text] [Related]
49. Disease modifying treatment for feline rheumatoid arthritis.
Hanna FY
Vet Comp Orthop Traumatol; 2005; 18(2):94-9. PubMed ID: 16594204
[TBL] [Abstract][Full Text] [Related]
50. [Leflunomide in combination with TNF-blockers for Methotrexate intolerance].
Krüger K; Manger B;
Z Rheumatol; 2009 Mar; 68(2):165-8. PubMed ID: 19159938
[No Abstract] [Full Text] [Related]
51. The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.
Finckh A; Dehler S; Gabay C;
Ann Rheum Dis; 2009 Jan; 68(1):33-9. PubMed ID: 18230627
[TBL] [Abstract][Full Text] [Related]
52. [Efficacy and safety of treatment with methotrexate, leflunomide, detralex, and their combination of patients with rheumatoid arthritis].
Shevchuk SV; Stanislavchuk MA; Pentiuk OO
Lik Sprava; 2003; (3-4):34-41. PubMed ID: 12889354
[TBL] [Abstract][Full Text] [Related]
53. A case of eczematous and vesicular dermatitis during anti-TNFalpha therapy for rheumatoid arthritis.
Savoia F; Gaddoni G; Casadio C; Spadola G; Patrizi A; Giacomini F; Aldi M
G Ital Dermatol Venereol; 2011 Aug; 146(4):308-9. PubMed ID: 21785399
[No Abstract] [Full Text] [Related]
54. Newer approaches to the treatment of rheumatoid arthritis.
Finesilver AG
WMJ; 2003; 102(7):34-7. PubMed ID: 14711022
[TBL] [Abstract][Full Text] [Related]
55. Severe leukopenia in a rheumatoid arthritis patient treated with a methotrexate/leflunomide combination.
Toth P; Bernd R
Rev Bras Reumatol; 2014; 54(2):152-4. PubMed ID: 24878863
[TBL] [Abstract][Full Text] [Related]
56. Leflunomide in combination therapy for rheumatoid arthritis.
Savage RL
Drug Saf; 2010 Jun; 33(6):523-6. PubMed ID: 20486733
[No Abstract] [Full Text] [Related]
57. The role of concomitant methotrexate in biologic therapy for rheumatoid arthritis.
Ruderman EM
Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S29-32. PubMed ID: 24219038
[TBL] [Abstract][Full Text] [Related]
58. Comparative effectiveness of tocilizumab with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
Narváez J; Díaz-Torné C; Magallares B; Hernández MV; Reina D; Corominas H; Sanmartí R; de la Serna AR; Llobet JM; Nolla JM
PLoS One; 2015; 10(4):e0123392. PubMed ID: 25830224
[TBL] [Abstract][Full Text] [Related]
59. Comparative study of the clinical efficacy of four DMARDs (leflunomide, methotrexate, cyclosporine, and levamisole) in patients with rheumatoid arthritis.
Popovic M; Stefanovic D; Pejnovic N; Popovic R; Glisic B; Obradovic S; Dimitrijevic M
Transplant Proc; 1998 Dec; 30(8):4135-6. PubMed ID: 9865325
[No Abstract] [Full Text] [Related]
60. Liver toxicity is rare in rheumatoid arthritis patients using combination therapy with leflunomide and methotrexate.
Alves JA; Fialho SC; Morato EF; Castro GR; Zimmermann AF; Ribeiro GG; Neves FS; Pereira IA
Rev Bras Reumatol; 2011; 51(2):141-4. PubMed ID: 21584420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
